Cargando…
The new and recurrent FLT3 juxtamembrane deletion mutation shows a dominant negative effect on the wild-type FLT3 receptor
In acute myeloid leukemia (AML), the Fms-like tyrosine kinase 3 (FLT3) is one of the most frequently mutated genes. Recently, a new and recurrent juxtamembrane deletion mutation (p.Q569Vfs*2) resulting in a truncated receptor was identified. The mutated receptor is expressed on the cell surface and...
Autores principales: | Sandhöfer, Nadine, Bauer, Julia, Reiter, Katrin, Dufour, Annika, Rothenberg, Maja, Konstandin, Nikola P., Zellmeier, Evelyn, Tizazu, Belay, Greif, Philipp A., Metzeler, Klaus H., Hiddemann, Wolfgang, Polzer, Harald, Spiekermann, Karsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921855/ https://www.ncbi.nlm.nih.gov/pubmed/27346558 http://dx.doi.org/10.1038/srep28032 |
Ejemplares similares
-
Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia
por: Reiter, K, et al.
Publicado: (2018) -
Microenvironmental Hypoxia regulates FLT3 expression and biology in AML
por: Sironi, Silvia, et al.
Publicado: (2015) -
Clonal heterogeneity of FLT3-ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemia
por: Schranz, Katrin, et al.
Publicado: (2018) -
Clinical and molecular features of
FLT3
juxtamembrane domain missense mutations in acute myeloid leukaemia
por: Jensen, Christopher E., et al.
Publicado: (2022) -
Deletion and deletion/insertion mutations in the juxtamembrane domain of the FLT3 gene in adult acute myeloid leukemia
por: Deeb, Kristin K., et al.
Publicado: (2014)